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ABSTRACT
Bacterial RNA polymerase is able to initiate tran-
scription with adenosine-containing cofactor NAD+,
which was proposed to result in a portion of cellu-
lar RNAs being ‘capped’ at the 5′ end with NAD+,
reminiscent of eukaryotic cap. Here we show that,
apart from NAD+, another adenosine-containing co-
factor FAD and highly abundant uridine-containing
cell wall precursors, UDP-Glucose and UDP-N-
acetylglucosamine are efficiently used to initiate
transcription in vitro. We show that the affinity to
NAD+ and UDP-containing factors during initiation
is much lower than their cellular concentrations, and
that initiation with them stimulates promoter escape.
Efficiency of initiation with NAD+, but not with UDP-
containing factors, is affected by amino acids of
the Rifampicin-binding pocket, suggesting altered
RNA capping in Rifampicin-resistant strains. How-
ever, relative affinity to NAD+ does not depend on
the −1 base of the template strand, as was sug-
gested earlier. We show that incorporation of ma-
ture cell wall precursor, UDP-MurNAc-pentapeptide,
is inhibited by region 3.2 of  subunit, possibly pre-
venting targeting of RNA to the membrane. Overall,
our in vitro results propose a wide repertoire of po-
tential bacterial RNA capping molecules, and provide
mechanistic insights into their incorporation.
INTRODUCTION
For few decades multi-subunit RNA polymerase (RNAP)
from Escherichia coli was known to be able to start RNA
synthesis with cellular nucleotide coenzymes, adenosine
derivatives NAD+ (nicotinamide adenine dinucleotide),
NADH (reduced form of NAD+) and FAD (flavin adenine
dinucleotide) (1). Authors of this work suggested that co-
factor moiety could function analogously to the eukary-
otic mRNA cap. Until very recently, the physiological sig-
nificance of this discovery remained obscure, and the ac-
cepted view was that non-processed bacterial RNAs carry
5′ triphosphate. In the last few years however, the data
started to accumulate that some cellular RNAs carry cap-
like structure––E. coli and Streptomyces venezuelae bear
NAD+ at the 5′ end (2). In 2015 those RNAs in E. coliwere
captured via 5′ NAD+ moiety and identified by next gen-
eration sequencing (3). It transpired that those RNAs were
mainly regulatory sRNA and somemRNAs. Only relatively
small proportion of the whole population of the particular
RNAwas NADylated in vivo. The most heavily NADylated
were RNAI and CopA, abundant short antisense RNAs
controlling pUC19 plasmid replication. Notably, for the
NADylated transcripts with known start site, the +1 posi-
tion coded for A, suggesting that it is RNAP incorporates
NAD+ at the 5′ end of RNA via mechanism shown earlier,
rather than some post-transcriptional mechanism being in-
volved (2). While our paper was in preparation, biochem-
ical and structural data using specific promoter assays has
been published that confirmed the promoter-dependent and
sequence-specific incorporation of NAD+, NADH and 3′-
dephosphocoenzyme A (dpCoA) (4). Correlation between
efficiencies of NAD+ incorporation in vitro and the extent
ofNADylation in vivo on two different promoters suggested
that transcription might be the main, if not the only, cap-
ping mechanism. Crystal structures of initiation complex
containing dinucleotideRNAproducts (to avoid confusion,
here and after, we refer to the RNA length counting NAD+
and other dinucleotide co-factors as a single nucleotide)
initiated with adenosine triphosphate (ATP), NAD+ and
dpCoA were solved for Thermus thermophilus RNAP (4)
demonstrated that, apart from interactions common for all
three cofactors, contacts of NAD+ moiety additionally in-
clude side chains of  subunits residues D516 and H1237.
The authors also proposed that nicotinamide moiety of
NAD+ may rotate to interact with the −1 position of the
template, thus explaining different efficiencies of NAD+ in-
corporation on different promoters.
Eukaryotic mRNA turnover depends on the efficiency of
cap removal. Major catalytic role in decapping in eukary-
otes is played by NUDIX motif-containing protein Dcp2p.
In bacteria, NudC (NADH pyrophosphohydrolase), which
contains NUDIX motif was shown to de-cap RNAs from
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NAD+ (5). Notably, NudC has much higher affinity to-
wards NADylated RNA compared to NAD+ itself (5). Ex-
istence of decapping mechanism makes the analogy be-
tween prokaryotic and eukaryotic RNA processing even
stronger.
In eukaryotes mRNA capping plays vital role in RNA
degradation, splicing, translation initiation and nuclear ex-
port. Physiological significance of bacterial RNA capping is
not yet clear. The only role for capping that was put forward
and got some experimental backing, is the protection of the
transcript from degradation. The data on capped RNA sta-
bility are, however, conflicting. Bird et al. reported 3- to 4-
fold increase of in NADylated RNAI stability in NudC
cells (lacking de-capping activity) (4), in contrast to another
study, where deletion of NudC did not affect the overall sta-
bility of RNAI and GcvB, two RNAs, most heavily NADy-
lated in vivo (3). Moreover, some RNAs with high NAD+
cap content are inherently very stable, for example sroBwith
half-life of more than 32 minutes (6). All these data suggest
possible additional roles for prokaryotic capping apart from
RNA stability.
To date only ADP analogues were identified as caps,
NAD+ and/or NADH. Cells use a number of nucleotide
cofactors and these might be just the first identified ones
among many substrates used by RNAP for RNA capping.
There are several poorly characterized NUDIX hydrolases
in E. coli, which can potentially serve to remove capping
molecules different from NAD+ (7), which have not been
found yet.
Here we provide further insights into the mechanism
of capping with adenine containing cofactors (NAD+,
NADH, NADP+, FAD) and its possible role in transcrip-
tion. We also show that the repertoire of potential cap-
ping molecules is wider, and includes uridine containing
precursors of cell wall synthesis (UDP-glucose and UDP-
N-acetylglucosamine). Our data also suggest the role of re-
gion 3.2 of initiation factor sigma in guarding transcription
against incorporation of ‘long-tailed’ NTP analogues into
RNA.
MATERIALS AND METHODS
Materials
ATP and UTP were from GE Healthcare; AMP, ADP,
NAD+, NADH, NADP+, FAD, UMP, UDP, UDG-
Glc and UDP-GlcNAc were from Sigma Aldrich; UDP-
MurNAc pentapeptide was a kind gift from Prof. Vollmer.
Proteins
Mutations in E. coli rpoB gene were constructed by site-
directed mutagenesis in polycistronic expression plasmid
pGEMABC, coding for RNAP core subunits ,  and ’
(8). Those subunits were overexpressed in E. coli T7 ex-
press strain (New England Biolabs) together with  sub-
units from expression plasmid pRSFD 2 rpoZ (8). Wild-
type and mutant RNAPs core enzymes were purified as de-
scribed in (9). RpoS gene encoding S was cloned into ex-
pression vector pET28, as previously were 70 and 703.2
(10). N-terminal Hisx6-tagged 70, 703.2, S were ex-
pressed from overexpression vector pET28 and purified as
described in (11).
In vitro transcription
A total of 0.3 pmols of wild-type or mutant RNAP core
with 1 pmols of70 (wild-type ormutant) orS and 2 pmols
of promoter-containing linear DNA fragment were incu-
bated at 37◦C for 10 min in 10 l of transcription buffer
(20 mM Tris–HCl (pH 7.9), 40 mM KCl, 0.1mM ethylene-
diaminetetraacetic acid) at 37◦C, then nucleotides or nu-
cleotides analogues were added to the final concentration
of 500 M (unless otherwise indicated). Transcription was
initiated by the addition of 10 mM MgCl2, 50 M (32P)-
CTP, 12.5Ci/mmol (Hartmann Analytic) for RNAI and
acnA templates; for T7A1 template 50 M (32P)-UTP,
12.5 Ci/mmol of were used. Reactions were stopped af-
ter 3 min incubation at 37◦C (unless otherwise indicated)
by the addition of formamide-containing loading buffer.
For the kinetics of synthesis of 9 nt-long transcript from
RNAImod, 500 M ATP or NAD+ were incubated with
promoter complex and then 20MUTPand 20M(32P)-
CTP, 12.5 Ci/mmol were added in the absence or presence
of 5 g/ml of Rifampicin. Reactions were stopped after pe-
riods of time indicated on Figure 4A. Products were sepa-
rated on denaturing polyacrylamide gels (30% acrylamide,
3% bis-acrylamide, 6M urea, 0.5 Tris-borate EDTA buffer),
revealed by PhosphorImaging (GE Healthcare), and anal-
ysed using ImageQuant software (GEHealthcare). For 9-nt
long RNA synthesis in Figure 2D on RNAImod template
500 M of either ATP, NAD+, NADH, NADP or FAD
were incubated with promoter complex and then 25 M
UTP and 25 M (32P)-CTP, 12.5 Ci/mmol, were added
and reactions were incubated for 10 min. For similar ex-
periment on Figure 5C to synthetize 12-nt long RNA on
acnA template 500 M of either UTP, UDP-Glc or UDP-
GlcNAc were incubated with promoter complex and then
25 M ATP and 25 M (32P)-CTP, 12.5 Ci/mmol, were
added and reactions were incubated for 10 min. For appar-
ent Km determination on RNAImod and acnA templates
NTPs and analogues were used in concentrations ranging
from 10 M to 10 mM and constant 50 M CTP (second
NTP for both templates) concentration. Reactions were in-
cubated for periods of time chosen to get approximately
the same intensities of the product bands. The bands inten-
sities were quantified using ImageQuant software; to cal-
culate the initial reaction rate these numbers were divided
by reaction duration time. These data were fitted to hy-
perbolic equation using non-linear regression procedure in
SigmaPlot software.
RESULTS
Escherichia coli RNAP is able to initiate transcription using
adenosine diphosphate analogues
Abortive production of short oligonucleotides is the very
first stage of the synthesis of the RNA. These products
can be resolved in high density denaturing polyacrylamide
gel. We analysed the efficiency of incorporation of poten-
tial cap molecules into RNA in abortive synthesis by E.
coli RNAP 70 holoenzyme on a linear DNA containing
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Figure 1. ADP-related cellular cofactors are utilized by RNAP for initiation of transcription. (A) Structures of ATP, NAD+, NADP+, FAD, UDP, UDP-
Glc (GlcUDP), UDP-GlcNAc (GlcNAcUDP) and UDP-MurNAc pentapeptide (5AAMurNAcUDP). (B) Templates (partial sequence of non-template
strand around transcription start site) used for in vitro experiments containing T7A1, RNAI promoters and RNAI template with modified initially tran-
scribed sequence, RNAImod. +1 position for all templates is in bold, −1 position is framed, 9 nt initially transcribed sequence in RNAImod is underlined.
(C) Initial transcript synthesis on RNAImod template using RNAP holo 70, holo S and holo703.2 and 500M ATP, NAD+, NADH, NADP+ and
FAD as initiating substrates and (32P)-CTP as the next nucleotide. (D) Plot reflecting incorporation efficiencies for alternative substrates in percentage
from efficiency of ATP incorporation for RNAP holo 70, holo S and holo703.2 on RNAImod, the values are an average of the three independent
experiments, error bars represent plus and minus one standard deviation.
promoter RNAI (that was shown to be the most heavily
modified by NAD+ in E. coli). ATP or co-enzymes (each
at 500 M concentration) (structures on Figure 1A) were
extended by (32P)-CMP (at 50 M). Position +3 of the
RNAI promoter wasmutated to T tomake RNAImod tem-
plate (here and after we refer to the sequence of the non-
template strand) to preclude extension of RNA further than
position +2, which would obscure kinetics analysis (Figure
1B). As can be seen from Figure 1C, NAD+, NADH, FAD
can be efficiently incorporated into the 2-nt long transcript.
The results are consistent with the recently published work
(4) and the earlier study (1). Efficient incorporation of these
coenzymes into the transcript is not a particular property of
RNAI, as they were similarly efficiently extended by (32P)-
UMP on a strong promoter A1 from bacteriophage T7,
where transcription also starts withA (Figure 2A). NADP+
was incorporated very inefficiently into the transcript on
both templates, likely due to the 2′-phosphate group ster-
ical hindrance during phosphodiester bond formation. At
1 mM initiating NAD+ and ATP on RNAImod template,
the kinetics of formation of NAD+pC was comparable (∼2
times slower) to that of pppApC (Figure 2B). The Kms for
ATP, NAD+ and NADH in initiation on RNAImod tem-
plate were 90 ± 11 M, 358 ± 67 M and 380 ± 72 M,
respectively, which is much lower than their cellular concen-
trations (see ‘Discussion’ section).
In the presence of CTP and UTP, the short transcripts
initiated with NAD+, NADH and FAD on the RNAImod
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Figure 2. Biochemical characterization of the ADP analogues incorporation into a transcript. (A) Initial products synthetized using ATP and cofactors as
initiating substrates on T7A1 promoter template with RNAP holo70Escherichia coli and (32P)-UTP as next nucleotide. (B) Kinetics of initial product
synthesis on RNAImod template with RNAP holo70 with either ATP or NAD+ as initiating substrate. (C)Km for ATP andNAD+ as initiating substrates
measured on RNAImod templates with different identity of −1 template bases (sequences in Figure 1B); numbers that follow the ±sign are errors that are
standard deviations of the fitting. (D) Transcripts initiated with ATP, NAD+, NADH, NADP+ and FAD, are elongated to 9 nt transcript on RNAImod
template.
template were efficiently extended into 9-nt products (Fig-
ure 2D). The amounts of 9-nt products were comparable to
those initiated with ATP, suggesting that, similar to NAD+
capping, NADH and FAD capping may exist in the cell.
Note also that the efficiency of abortive products extension
(the ratio between 9-nt RNA and dinucleotides) in the case
of co-factors was higher than in the case of ATP, suggesting
that co-factors increase efficiency of promoter escape (see
below).
The −1 position of template does not influence the relative
efficiency of NAD+ versus ATP incorporation into the tran-
script
Nicotinamide moiety may, in theory, form base pair with
template DNA base at the position −1. This may change
specificity ofNADylation at promoters with particular base
at −1 position. It was observed that A to C (non-template
strand) change in −1 position decreased the overall effi-
ciency of NADylated transcript synthesis (4). To test if the
base at position −1 affects the affinity to NAD+, we used
linear templates with RNAImod promoter variants with
changes in the −1 position (Figure 1B). We measured ap-
parent Km for NAD+ and ATP on these four promoters
variants in abortive synthesis as above (Figure 2C). We
found that Km for NAD+ incorporation in transcript was
lower for templates with C and T in −1 position compared
with values for−1 A or G. However, the same tendency was
observed for incorporation of ATP, suggesting that posi-
tion −1 of template does not specifically affect affinity to
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Figure 3. Aminoacids of Rifampicin-binding pocket of  subunit of RNAP influence incorporation of ADP analogues into a transcript. (A) Crystal
structure of the initiation complex with NAD+pC product with Thermus thermophilus RNAP, adapted from PDB ID: 5D4D (4). The amino acids of
Rif-pocket, whose changes were tested in vitro are in purple (Escherichia coli numbering), NAD+ is in yellow, DNA is in blue, −1 and +1 positions of the
templates are indicated. (B) Relative efficiency of incorporation of 500 M NAD+ versus ATP into dinucleotide product on RNAImod template by WT
and mutant RNAPs with aminoacid changes in  subunit indicated below the plot. The values are an average of the three independent experiments, error
bars represent plus and minus one standard deviation.
NAD+. This result is consistent with crystal structures of
the initiating complexes where initiating NAD+ makes the
same contacts with template DNA as initiating ATP (4).
Therefore it is likely that different steps of initiation, rather
than direct interaction with the template, may influence the
relative efficiency of initiation with NAD+ on templates
with different −1 position (4). Note that the measured Kms
for NAD+ on either of the templates are much lower than
the cellular concentrations (see ‘Discussion’ section).
Core RNAP determinants for NAD+ incorporation
We tested if there are any other structural determinants
for cofactors incorporation apart from −1 position of tem-
plate. 5′ NTP of the growing transcript passes through the
Rifampicin-binding pocket of the  subunit of RNAP. It
was shown that  -phosphate of the initiating ATP is in
proximity to the  subunit fragment between amino acids
516 and 540 (12), suggesting where the nicotinamide group
of NAD+ could be bound during initiation. We tested
several RNAPs with amino acid changes in Rifampicin-
binding pocket (Rif pocket) –– Q513L, F514A, D516V,
D516Y, H526Y, H526R, H526P, S531L, N568A, I572F on
RNAImod promoter with either NAD+ or ATP as an ini-
tiating substrate. The activities of the enzymes in abortive
synthesis varied significantly (either due to specific activi-
ties of the enzymes or distortion of the Rif pocket). Fig-
ure 3B shows relative efficiencies of NAD+ incorporation
(NAD+/ATP ratio) by the mutant enzymes in percentage
from that of the WT RNAP. Indeed, in agreement with
our hypothesis that part of NAD+ maybe bound in the Rif
pocket, the effect was dependent both on the position and
nature of the amino acid substitution. The strongest effect
on NAD+ utilization was produced by mutations of D516
of  (Figure 3B). This corroborates the crystal structure of
the initiating complex with NAD+ primed RNA product,
where theD516 side chain is in close proximity of the nicoti-
namide moiety of the NAD+ (4) (Figure 3A). Changes of
other aminoacids that are too far to interact with NAD+
directly, perhaps affect the overall shape of the Rif-pocket.
Initiation factor does not play a role in selectivity of ADP-
containing co-enzymes as substrates
A larger proportion of RNAI was found to be NADylated
in stationary growth phase compared to the exponential
phase (3). In stationary phase most transcripts are made by
RNAP holoenzyme containing S, while housekeeping 70
operates in exponential phase. We analysed if different ini-
tiation factors may dictate specificity towards capping co-
factors. To answer this question we tested initiation with
NAD+ onRNAI promoter with holo 70 and holo S (Fig-
ure 1C and D). The rates of abortive products formation
with ATP, NAD+, NADH, NADP+ and FADwere similar
for both RNAPs (Figure 1C and D). Km values for NAD+
were also close for both holoenzymes (358± 67Mfor holo
70 and 352± 88Mfor holoS) The results suggest that at
least the two initiation factors tested do not provide signif-
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icant specificity towards utilization of NAD+ as initiation
substrate.
Previous functional and structural analyses suggested
that region 3.2 of  subunit protrudes towards catalytic
site of the RNAP and may contact the 5′ end of short
transcripts (10,11,13,14). We tested initiation with NAD+,
NADH, NADP+ and FAD (500 M) on RNAI promoter
by holoenzymes containing either wild-type 70 or mutant
70 lacking region 3.2, 703.2 (Figure 1C and D). We did
not observe any significant differences in specificity, sug-
gesting that region 3.2 does not make contacts critical for
cofactors’ binding.
NADylation of transcript stimulates escape of the RNAP
from promoter
From our results it follows that NAD+ interacts differently
with RNAP as compared to ATP. These differences might
affect stability of the short abortive transcripts, and as a re-
sult, their extension during promoter escape. We therefore
tested kinetics of 9-nt RNA production initiated with ei-
ther ATP or NAD+ (500 M) on RNAImod template. A
relatively low concentration of CTP and UTP (20 M) al-
lowed us to monitor the accumulation of short RNAs rang-
ing from 2 to 9 nt in length. As can be seen from Figure
4A and B there were much less accumulation of the 2- and
3-nt long transcripts when transcription was initiated with
NAD+ as compared to ATP (compare the traces of 600 s
products in Figure 3B). Rifampicin is known to block es-
cape into elongation, with concomitant increase of abortive
synthesis (15). We hypothesized that, if NAD+ containing
initial transcripts are bound tighter by RNAP than ATP
containing ones, Rifampicin may have different effect on
their release. We used low concentration of Rifampicin (5
g/ml), which was not enough to block transcription com-
pletely. Addition of Rifampicin to reaction inhibited pro-
duction of 9-nt RNA initiated by either ATP or NAD+.
Also, as expected Rifampicin increased release of pppApC
dinucleotide. However, Rifampicin almost didn’t affect pro-
duction of NAD+ containing short RNAs, highlighting the
difference between promoter escape with ATP and NAD+
(compare the traces of 600 s products in Figure 3B). These
results suggest that NAD+ moiety at the 5′end indeed can
stabilize short transcripts in the RNAP active centre.
UDP derivatives can serve as initiating substrates for tran-
scription
Exponentially growing in rich medium E. coli cells con-
tain high concentrations of a number of nucleotide ana-
logues potentially capable of initiating transcription. One
of the most abundant small molecules in E. coli cell, second
only to ATP, is UDP-N-acetylglucosamine (UDP-GlcNAc)
(16), which participates in formation of peptidoglycan,
lipopolysaccharides and teichoic acid cell wall components.
We tested if UDP-GlcNAc, along with another precursors
of cell wall synthesis, Uridine 5′-diphosphoglucose (UDP-
Glc) (structures in Figure 1A) can initiate transcription.
We also tested a more complex compound, UDP-MurNAc
pentapeptide (Figure 1A), the last-step precursor before the
formation of Lipid I, a building block of the cell wall.
In this experiment we used linear templates containing
acnA promoter, on which transcription starts with UTP
(Figure 5A). We analyzed initiation from UDP-Glc, UDP-
GlcNAc, UDP-MurNAc pentapeptide (5AA-MurNAc),
along with UMP, UDP and UTP as controls (each at 500
M concentrations) (Figure 5A) by monitoring synthesis
of the dinucleotide transcript after addition of an (32P)-
CMP (at 50 M concentration). As can be seen from Fig-
ure 5A, E. coli RNAP can efficiently incorporate UDP-Glc
and UDP-GlcNAc (comparably to UTP; lanes 3–5). The
Km values on the acnA promoter for UDP-Glc and UDP-
GlcNAc were 300 ± 62 M and 333 ± 41 M, respec-
tively (compared to 120 ± 17 M for UTP). These Km val-
ues are well below intracellular concentrations of UDP-Glc
and UDP-GlcNAc in exponential growth phase (2.5 and
9.2mM, respectively).We analysed if dinucleotides initiated
withUDP-Glc andUDP-GlcNAc can be extended to facili-
tate escape into elongation.Wemutated acnApromoter (ac-
nAmod; Figure 5A) so that we could monitor extension to
12-nt RNA in the presence of the ATP and CTP. As can be
seen fromFigure 5C, the transcripts initiatedwithUDP-Glc
and UDP-GlcNAc were elongated by RNAP to the 12 nt.
Note also, that the efficiency of promoter escape withUDP-
Glc and UDP-GlcNAc was higher than that with UTP.
These findings suggest that the cell wall precursors UDP-
Glc and UDP-GlcNAc may serve as an RNA caps in vivo.
Interestingly, UDP-MurNAc pentapeptide was not uti-
lized by RNAP at all. It is possible that RNAP possesses a
mechanism that prevents incorporation of UDP-MurNAc
pentapeptide into an RNA, which would be too costly for
cells and may lead to unwanted targeting of the modified
transcript towards the membranes. One of the possible ob-
stacles for the pentapeptide in the active site could be region
3.2 of 70. We therefore analysed incorporation of UMP,
UDP, UTP, UDP-Glc, UDP-Glc NAc and UDP-MurNAc
pentapeptide (500 M) by holoenzymes formed with wild-
type 70 or 703.2. As can be seen from Figure 5A, the
mutant RNAP indeed acquired partial ability to incorpo-
rate UDP-MurNAc pentapeptide, while usage of smaller
cell wall precursors was not affected (see also relative effi-
ciencies of dinucleotide formation in Figure 5B). This result
suggests that region 3.2 may participate in guarding against
incorporation of the cellular nucleotide analogues with long
side chains.
To test if Rif-pocket plays role in selectivity of UDP-
GlcNAc utilization in initiation, as it does for ADP-
containing co-factors, we tested the activities of Rifampicin
resistant mutant RNAPs that we used above. Mutant
RNAP with Q513I substitution was inactive on acnA even
with UTP, and was excluded from analysis. The rest of mu-
tations in Rif-pocket did not affect incorporation of UDP-
GlcNAc into the transcript strongly (Figure 5D), suggest-
ing that UDP-GlcNAc may not make specific contacts with
amino acids of the Rif-pocket.
DISCUSSION
Here we showed that RNAP is able to incorporate variety
of cellular cofactors at the 5′end of the transcript, suggest-
ing a possibility of a wide repertoire of RNA caps in bacte-
ria. In addition to NAD+ that had been shown to cap some
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Figure 4. NAD+ as initiating substrate improves escape of RNAP from promoter compared to ATP. (A) Kinetics of synthesis of 9 nt transcript on
RNAImod promoter template (Figure 1B) using either ATP or NAD+ at 1 mM, 20 M (32P)-CTP and 20 M UTP in the absence or presence of 5
g/ml of Rifampicin. (B) Signal traces taken across the 600 s bands.
of bacterial RNAs in vivo, another adenine containing co-
factor FADcan also be incorporated byRNAP in sequence-
dependentmanner, and thus capRNAs on+1A (T in the +1
position of the template strand) promoters. Furthermore,
we show that UDP-containing cell wall precursors may ef-
ficiently cap RNAs on +1U promoters.
The crystal structure of promoter complex with NADpC
dinucleotide transcript showed the interactions of nicoti-
namidemoiety with the Rif-pocket of  subunit (4). Indeed,
all amino acid substitutions in the Rif-pocket we tested in
our experiments specifically decreased the ability of RNAP
to incorporate NAD+, thus confirming the structural ob-
servations. We observed that substitutions at position 516
are the most detrimental for NAD+ incorporation, consis-
tent with the contacts of nicotinamide moiety with D516
seen in the structure. Interestingly,Rifampicin resistant sub-
stitutions at positions 516, 526 and 531 that strongly inhib-
ited NAD+ incorporation, are those most frequent found
in clinic (17). The control of the RNA capping by the Rif-
pocket may be involved also after the cap binding in the ac-
tive centre, at the stage of RNA extension and promoter
escape. Indeed, we found that transcription started with
NAD+ produced far less of short abortive products than
transcription started with ATP on the same promoter.
The crystal structure of the promoter complex with the
NADpC revealed that nicotinamide moiety does not inter-
act with the template (4). The authors however observed
that a change in the−1 position of the template may change
the proportion of NADylated RNAs when both ATP and
NAD+ are used in the reaction. They suggested that nicoti-
namide moiety might change conformation to interact with
the template base in −1 position, which has not been cap-
tured in the crystals. Although we found thatKm for NAD+
for promoters with−1C or−1Twere lower compared to the
promoters with−1G or A, the same tendency was observed
for ATP, suggesting that the preference of NAD+ for −1
position is not explained by specific base-pairing of nicoti-
namide moiety with the −1 position of the template. We
therefore suggest that −1 position of the promoter affects
the properties of other steps(s) of initiation, thus affecting
the efficiency of RNA NADylation.
Region 3.2 of the  subunit is in close proximity to the
Rif-pocket (8) and may serve as another determinant for
an efficiency of incorporation of the cofactors. However,
we did not find any significant effect of the deletion of re-
gion 3.2 on incorporation of either NAD+, NADH, FAD
or NADP, as compared to ATP. We also observed no dif-
ference in efficiency of usage of these factors by RNAP
equipped with either housekeeping 70 versus stationary
phase S initiation factor. These results suggest that  sub-
units do not directly interact with the initiating co-enzymes.
We however cannot exclude that other alternative initia-
tion factors can contribute towards or against incorpora-
tion of non-canonical capping nucleotides analogues. Fur-
thermore,  region 3.2 may affect the relative efficiency
of capping by its interactions with the template DNA up-
stream of the start site, thus affecting escape into productive
elongation.
We further extended the potential bacterial RNA cap
repertoire to derivatives of UDP, the highly abundant pre-
cursors of cell wall components. Interestingly we found that
while  region 3.2 did not have effect on the incorporation
of UDG-Glc and UDP-GlcNAc, it did inhibit incorpora-
tion of a larger UDP-MurNAc pentapeptide. The protec-
tion of more complex cell wall precursor from incorpora-
tion into RNA may have biological significance. The more
complex precursors are more expensive for the cell than ini-
tial precursorsUDG-Glc andUDP-GlcNAc. Furthermore,
modification of the 5′ end of RNA with UDP-MurNAc
pentapeptide may potentially lead to targeting of an RNA
to a membrane, thus affecting its expression.
K m values for NAD+ are in the range of 100–400 Mon
various promoter variants, which is below published intra-
cellular concentration of 2.3 mM in exponential E. coli cells
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Figure 5. Analogues of UDP can serve as initiating substrates for RNAP in vitro. (A) Template with acnA promoter (partial sequence around transcription
start site) and acnAmod template, +1 position is in bold, 12 nt initially transcribed sequence in RNAImod is underlined. Dinucleotide synthesis on acnA
template using either RNAP holo 70 or holo 703.2, and 500 M UMP, UDP, UTP, UDP-Glc, UDP-GlcNAc and UDP-MurNAc pentapeptide as
initiating substrates and (32P)-CTP as the next nucleotide. (B) Plot below the gel represents the ratio of incorporation of indicated substrates by holo
703.2 versus holo 70, the values are an average of the two independent experiments, error bars represent plus and minus one standard deviation. (C)
Transcripts initiated with UTP, UDP-Glc, UDP-GlcNAc, are elongated to 12 nt transcript on acnAmod template. (D) Relative efficiency of incorporation
of 500 MUDP-GlcNAc in comparison to UTP into dinucleotide product on RNAImod template by WT and mutant RNAPs with aminoacid changes
in Rifampicin-binding pocket of  subunit indicated below the plot. The values are an average of the two independent experiments, error bars represent
plus and minus one standard deviation.
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grown with glucose (16). Km values for the UDP-GlcNAc
and UDP-Glc (both in the range of ∼300 M) on acnA
promoter are also far lower the cellular concentration of
these compounds (∼9 and 2.3 mM, respectively) (16), and
thus are even more favorable for RNA capping. In addition
to NudC, which was shown to uncap NAD-RNAs, there
are 13 poorly characterized NUDIX hydrolases in E. coli,
which can potentially remove capping molecules, hypothet-
ically including FAD and derivatives of UDP (7).
There might be an unexpected connection between cap-
ping (and thus potentially gene expression) and the effect of
various antibiotics. For example, inhibition of protein syn-
thesis by chloramphenicol or tetracycline, as well as inhi-
bition of cell wall biosynthesis by fosfomycin lead to sig-
nificant increase of the UDP-GlcNAc concentration (18),
potentially changing capping efficiency for transcripts pro-
duced from +1U promoters. All tested Rifampicin resis-
tant mutants of RNAP have impaired NAD+ capping ac-
tivity most likely due to an altered geometry of Rif-pocket.
Therefore the reduced fitness of Rifampicin resistant mu-
tants (19), in part, may be attributed to the altered NADy-
lation of RNA resulting in aberrant regulation of RNA sta-
bility and thus gene expression. Furthermore, subinhibitory
concentrations of Rifampicin may have different effects on
production of RNA initiated with NTP and a co-factor, as
can be seen from Figure 4A.
Overall our work provides mechanistic insight into the
process of prokaryotic capping of RNA by RNAP with the
variety of cellular cofactors in vitro.
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